Gilead nears deal to buy Immunomedics for more than $20 bn: WSJ report
(Reuters) – Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more
Read more(Reuters) – Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more
Read moreGilead Sciences Inc said on Friday an analysis showed its antiviral remdesivir helped reduce the risk of
Read more